Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionArgyle Capital Management Inc.
Latest Disclosed Ownership2,375 shares
Latest Disclosed Value $ 362,781
Argyle Capital Management Inc. ownership in NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 28, 2026 - Argyle Capital Management Inc. filed a 13F-HR form disclosing ownership of 2,375 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $305,188 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 2,375 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $287,375 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F Novartis SPONSORED ADR 66987V109 2,375 0 0.00 363 10.70 0.1179
2026-01-29 2025-12-31 13F Novartis SPONSORED ADR 66987V109 2,375 0 0.00 327 7.57 0.1093
2025-10-27 2025-09-30 13F Novartis SPONSORED ADR 66987V109 2,375 0 0.00 305 5.92 0.1053
2025-07-24 2025-06-30 13F Novartis SPONSORED ADR 66987V109 2,375 0 0.00 287 8.71 0.1042
2025-04-29 2025-03-31 13F Novartis SPONSORED ADR 66987V109 2,375 0 0.00 265 14.29 0.0983
2025-02-05 2024-12-31 13F Novartis SPONSORED ADR 66987V109 2,375 0 0.00 231 -15.38 0.0911
2024-10-25 2024-09-30 13F Novartis SPONSORED ADR 66987V109 2,375 0 0.00 273 8.33 0.1088
2024-07-29 2024-06-30 13F Novartis SPONSORED ADR 66987V109 2,375 0 0.00 253 10.04 0.1040
2024-04-29 2024-03-31 13F Novartis SPONSORED ADR 66987V109 2,375 0 0.00 230 -4.18 0.0889
2024-02-05 2023-12-31 13F Novartis SPONSORED ADR 66987V109 2,375 -1,600 -40.25 240 -40.84 0.0994
2023-10-26 2023-09-30 13F Novartis A G SPONSORED ADR 66987V109 3,975 0 0.00 405 0.75 0.1483
2023-07-27 2023-06-30 13F Novartis A G SPONSORED ADR 66987V109 3,975 -2,075 -34.30 401 -27.88 0.1446
2023-04-27 2023-03-31 13F Novartis A G SPONSORED ADR 66987V109 6,050 0 0.00 557 1.46 0.1957
2023-02-06 2022-12-31 13F Novartis A G SPONSORED ADR 66987V109 6,050 0 0.00 549 19.13 0.1887
2022-10-21 2022-09-30 13F Novartis A G SPONSORED ADR 66987V109 6,050 0 0.00 460 -9.98 0.1792
2022-07-20 2022-06-30 13F Novartis A G SPONSORED ADR 66987V109 6,050 0 0.00 511 -3.77 0.1833
2022-04-27 2022-03-31 13F Novartis A G SPONSORED ADR 66987V109 6,050 0 0.00 531 0.38 0.1728
2022-01-25 2021-12-31 13F Novartis A G SPONSORED ADR 66987V109 6,050 0 0.00 529 6.87 0.1651
2021-10-25 2021-09-30 13F Novartis A G SPONSORED ADR 66987V109 6,050 0 0.00 495 -10.33 0.1639
2021-07-27 2021-06-30 13F Novartis A G SPONSORED ADR 66987V109 6,050 0 0.00 552 6.77 0.1784
2021-04-27 2021-03-31 13F Novartis A G SPONSORED ADR 66987V109 6,050 0 0.00 517 -9.46 0.1742
2021-01-28 2020-12-31 13F Novartis A G SPONSORED ADR 66987V109 6,050 -1,775 -22.68 571 -16.03 0.2125
2020-10-27 2020-09-30 13F Novartis A G SPONSORED ADR 66987V109 7,825 -800 -9.28 680 -9.69 0.2785
2020-07-22 2020-06-30 13F Novartis A G SPONSORED ADR 66987V109 8,625 0 0.00 753 5.91 0.3159
2020-04-27 2020-03-31 13F Novartis A G SPONSORED ADR 66987V109 8,625 0 0.00 711 -12.97 0.3359
2020-01-24 2019-12-31 13F Novartis A G SPONSORED ADR 66987V109 8,625 0 0.00 817 8.93 0.2901
2019-10-25 2019-09-30 13F Novartis A G SPONSORED ADR 66987V109 8,625 0 0.00 750 -4.82 0.2835
2019-07-25 2019-06-30 13F Novartis A G SPONSORED ADR 66987V109 8,625 0 0.00 788 -4.95 0.2990
2019-04-24 2019-03-31 13F Novartis A G SPONSORED ADR 66987V109 8,625 0 0.00 829 12.03 0.3186
2019-01-28 2018-12-31 13F Novartis A G SPONSORED ADR 66987V109 8,625 0 0.00 740 -0.40 0.3134
2018-10-26 2018-09-30 13F Novartis A G SPONSORED ADR 66987V109 8,625 0 0.00 743 13.96 0.2781
2018-08-14 2018-06-30 13F Novartis A G SPONSORED ADR 66987V109 8,625 -400 -4.43 652 -10.68 0.2585
2018-04-25 2018-03-31 13F Novartis A G SPONSORED ADR 66987V109 9,025 0 0.00 730 -3.69 0.2894
2018-01-25 2017-12-31 13F Novartis A G SPONSORED ADR 66987V109 9,025 0 0.00 758 -2.19 0.2839
2017-10-26 2017-09-30 13F Novartis A G SPONSORED ADR 66987V109 9,025 0 0.00 775 2.92 0.3041
2017-07-26 2017-06-30 13F Novartis A G SPONSORED ADR 66987V109 9,025 0 0.00 753 12.39 0.3057
2017-04-26 2017-03-31 13F Novartis A G SPONSORED ADR 66987V109 9,025 -58 -0.64 670 1.21 0.2735
2017-01-27 2016-12-31 13F Novartis A G SPONSORED ADR 66987V109 9,083 0 0.00 662 -7.67 0.2814
2016-10-24 2016-09-30 13F Novartis A G SPONSORED ADR 66987V109 9,083 -200 -2.15 717 -6.40 0.3108
2016-07-26 2016-06-30 13F Novartis A G SPONSORED ADR 66987V109 9,283 0 0.00 766 13.99 0.3253
2016-04-26 2016-03-31 13F Novartis A G SPONSORED ADR 66987V109 9,283 0 0.00 672 -15.89 0.3055
2016-01-29 2015-12-31 13F Novartis A G SPONSORED ADR 66987V109 9,283 0 0.00 799 -6.33 0.3680
2015-10-27 2015-09-30 13F Novartis A G SPONSORED ADR 66987V109 9,283 -200 -2.11 853 -8.57 0.4168
2015-07-29 2015-06-30 13F Novartis A G SPONSORED ADR 66987V109 9,483 -342 -3.48 933 -3.72 0.4268
2015-04-29 2015-03-31 13F Novartis A G SPONSORED ADR 66987V109 9,825 9,825 0.00 969 0.4334
2015-01-26 2014-12-31 13F Novartis A G SPONSORED ADR 66987V109 0 -9,825 -100.00 0 -100.00
2014-10-22 2014-09-30 13F Novartis A G SPONSORED ADR 66987V109 9,825 0 0.00 925 4.05 0.4260
2014-07-25 2014-06-30 13F Novartis A G SPONSORED ADR 66987V109 9,825 0 0.00 889 6.47 0.4145
2014-04-24 2014-03-31 13F Novartis A G SPONSORED ADR 66987V109 9,825 0 0.00 835 5.70 0.4100
2014-01-31 2013-12-31 13F Novartis A G SPONSORED ADR 66987V109 9,825 0 0.00 790 4.77 0.3977
2013-10-31 2013-09-30 13F Novartis A G SPONSORED ADR 66987V109 9,825 -200 -2.00 754 6.35 0.4139
2013-07-31 2013-06-30 13F Novartis A G SPONSORED ADR 66987V109 10,025 10,025 709 0.4064
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.